Endoscopic stenting in the management of malignant biliary obstruction;Tratamiento endoscópico de la patología maligna de la vía biliar mediante endoprótesis

Revista Espanola de Enfermedades Digestivas

Volumn 90, Issue 2, 1998, Pages 73-84

  Pellicer Bautista, F ^a   Martin Guerrero J M ^a   Fernandez Perez F J ^a   Hassan Asad, M ^a   Pallares Manrique H ^a   Romero Castro, R ^a   Hergueta Delgado, P ^a   Herrerias Gutierrez J M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

Biliar endoprostheses; Endoscopic management; Malignant biliary obstruction

Indexed keywords

AGED; ARTICLE; BILE DUCT; CLINICAL TRIAL; DIGESTIVE TRACT ENDOSCOPY; FEMALE; HUMAN; IMPLANTATION; MALE; MIDDLE AGED; OBSTRUCTIVE JAUNDICE; PROSTHESES AND ORTHOSES; RADIOGRAPHY;

AGED; AGED, 80 AND OVER; BILE DUCTS; CHOLESTASIS, EXTRAHEPATIC; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSTHESES AND IMPLANTS; PROSTHESIS IMPLANTATION;

EID: 0031994630     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Andersen JR, Sorensen SM, Kruse A, et al. Randomised trial of endoscopic stent versus operative bypass in malignant obtructive jaundice. Gut 1989;30:1132-5.
2. Shepard HA, Royle G, Ross APR, et al. Endoscopic biliary stent in the paliation of malignant obstruction of the distal common bile duct: a randomised trial. Br J Surg 1988;75:1166-8.
3. Smith AC, Dowsett JF, Russell RCG, et al. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction. Lancet 1994;344:1655-60.
4. Wosiewitz U, Schrameyer B, Zimmermann E. Investigation on the incrustation and obstruction of the bile duct endoprostheses. Acta Endoscopica 1985;15:395-402.
5. Groen AK, Out T, Huibregtse K, et al. Characterization of the content of occluded biliary endosprostheses. Endoscopy 1987;19:57-9.
6. Moesch C, Sauterreau D, Cessot F, et al. Physicochemical and bacteriological analysis of the contents of occluded biliary endosprostheses. Hepatology 1991;14:1142-6.
7. Carr-Locke DL, Ball TJ, Brandabur J, et al. Final results of a multicenter randomized trial of endoscopic Wallstent biliary endosprostheses versus plástic stents. World Congresses of Gastroenterology. Los Angeles, CA. October; 1994. p. 2513.
8. Smit JM, Out MMJ, Groen AK, et al. A placebo-controlled study on the efficacy of aspirin and doxcycline in preventing clogging of biliary endosprostheses. Gastrointest Endosc 1989;35:485-9.
9. Ghosh S, Palmer KR. Prevention of biliary stent occlusion using cyclical antibiotics and ursodeoxycholic acid. Gut 1994;35:1757-9.
10. Seitz U, Vadeyar H, Soehendra N. Prolonged patency with a new desing Teflon biliary prosthesis. Endoscopy 1994;26:478-82.
11. Davids HP, Groen AK, Rauws E, et al. Randomised trial of self-expanding metal stents versus plastic stents for malignant biliary obstruction. Lancet 1992;340:1488-92.
12. Wagner HJ, Knyrim K, Vakil N, et al. Polyethylene endosprostheses versus metal stents in the palliative treatment of malignant hiliar biliary obstruction. A prospective and randomised trial. Endoscopy 1993;25:213-8.
13. Knyrim K, Wagner HJ, Pausch J, et al. A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. Endoscopy 1993;25:207-12.
14. Adam A, Cherry N, Roddie M, et al. Self-expandable stainless steel endosprostheses for treatment of malignant bile duct obstruction. AJR 1991;156:321-5.
15. Huibregtse K, Carr-Locke DL, Cremer M, et al. Biliary stent oclussion: a problem solved with self-expanding metal stents? Endoscopy 1992;24:391-4.
16. Rossi P, Bezzi M, Rossi M, et al. Metallic stens in malignant biliary obstruction: results of a multicenter European study of 240 patients. J Vasc Interv Radiol 1994;5:279-85.
17. Hoepffner N, Foerster EC, Högemann B, et al. Long-term experience in Wallstent therapy for malignant choledocal stenosis. Endoscopy 1994;26:597-602.
18. Schmassmann A, Von Gunten E, Knuchel J, Scheurer U, Fehr HF, Halter F. Wallstent versus plastic stents in malignant biliar obstruction: effects of stent patency of the first and second stent on patient compliance and survival. Am J Gastroenterol 1996;91:654-9.
19. Mathieson JR, McLoughlin RF, Cooperberg PL, et al. Malignant obstruction of the common bile duct: long term results of Gianturco-Rosch metal stents used as initial treatment. Radiology 1994;192:663-7.
20. Fraskes JT, Johanson JF, Staken JJ. Optimal timing for stent replacement in malignant biliary tract obstruction. Gastrointest Endosc 1993;39:164-7.
21. Kadakia NC, Starnes E. Comparison of 10 french gauge stent with 11.5 french gauge stents in patients with biliary tract disease. Gastrointest Endosc 1992;38:454-9.
22. Dowidar N, Moesgaard F, Matzen P. Clogging and other complications of biliary endoprostheses. Scand J Gastroenterol 1991;26:1132-6.
23. Speer AG, Cotton P, McRea KD. Endoscopic management of malignant biliary obstruction: stent of 10 french gauge are preferable to stent of 8 french gauge. Gastrointest Endosc 1988;34:412-7.
24. Huibregtse K. Plastic or expandable biliary endoprotheses? Scand J Gastroenterol 1993;200(suppl):3-7.
25. Stoker J, Lameris JS, Van Blankenstein M. Percutaneous metallic self-expandable endoprostheses in malignant hiliar biliar obstruction. Gastrointest Endosc 1993;39(I):43-9.
26. Matsuda Y, Shimakura K, Akamatsu T. Factors affecting the patency of stents in malignant biliary obstructive disease: univariate and multivariate analysis. Am J Gastroenterol 1991;86:843-9.